374: Musculoskeletal toxicities in patients receiving concomitant statin and daptomycin therapy and the benefit of de-escalating ceftriaxone to cefazolin

Show notes at pharmacyjoe.com/episode374.

In this episode I’ll:
1. Discuss a review article about musculoskeletal toxicities in patients receiving concomitant statin and daptomycin therapy
2. Answer the drug information question “Is there any benefit in de-escalating ceftriaxone to cefazolin?”